Cordant Inc’s MetLife MET Stock Holding History

Cordant Inc’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-67	Closed	-$5K	–	776
2022 Q1	$5K	Buy	+67	New	+$4.53K	﹤0.01%	288

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cordant Inc's MET Position: Q2 2022 in Review

Cordant Inc sold out of MetLife (MET) in Q2 2022, closing a stake of 67 shares — an estimated $5K sold.

Cordant Inc first reported a position in MET in Q1 2022 and held it in 1 quarter. The position peaked at $5K in Q1 2022. 1,198 funds tracked by Wall St. Rank hold MET as of Q2 2022.

Cordant Inc reported no remaining MetLife position as of Q2 2022 after selling out during the quarter.
Cordant Inc sold 67 MetLife shares in Q2 2022, an estimated $5K.
Cordant Inc first reported a position in MetLife in Q1 2022 and held it in 1 quarter.
Cordant Inc's MetLife position peaked at $5K in Q1 2022.
1,198 funds tracked by Wall St. Rank held MetLife as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.